Are there any recent studies indicating that ketamine may cause clinically significant hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ketamine and Hypotension: Recent Evidence

Yes, recent studies from 2020-2025 demonstrate that ketamine causes clinically significant hypotension during rapid sequence intubation (RSI), contrary to traditional teaching about its sympathomimetic properties. This finding challenges the conventional wisdom that ketamine is hemodynamically neutral or protective.

Key Evidence from Recent Studies

Peri-Intubation Hypotension Rates

Recent high-quality evidence reveals concerning hypotension rates with ketamine:

  • In septic patients undergoing RSI, ketamine was associated with significantly more post-procedure hypotension (74%) compared to etomidate (50%), with an adjusted odds ratio of 2.7 (95% CI 1.1-6.7) 1

  • A large National Emergency Airway Registry study (n=6,806) found peri-intubation hypotension occurred in 18.3% of ketamine patients versus 12.4% with etomidate, with ketamine showing 1.4 times higher risk (95% CI 1.2-1.7) even after adjusting for confounders 2

  • A 2025 systematic review and meta-analysis of 7 randomized controlled trials (n=2,384) confirmed that ketamine probably increases hemodynamic instability in the peri-intubation period (RR 1.29; 95% CI 1.07-1.57; moderate certainty evidence) 3

Critical Caveat: Depleted Catecholamine Stores

The 2023 Society of Critical Care Medicine guidelines explicitly warn: "In critically ill patients with depleted catecholamine stores, there is concern for hypotension and cardiac arrest" with ketamine use 4. This is the crucial mechanism—ketamine's sympathomimetic effects depend on endogenous catecholamine release, which may be exhausted in critically ill patients 4.

Clinical Context and Nuances

When Hypotension Risk is Highest

The evidence suggests ketamine-associated hypotension is particularly problematic in:

  • Septic patients: Multiple studies show higher hypotension rates in this population 1, 4
  • Traumatic brain injury: A 2021 interrupted time-series analysis found a 5% increase in post-RSI hypotension (p=0.046) and an average 7.8 mmHg decrease in systolic blood pressure after ketamine introduction for TBI patients 5
  • Air medical transport: Ketamine was associated with higher incidence of both hypotension and cardiopulmonary arrest in this setting 6

Contradictory Evidence

One propensity-matched study in septic patients found the opposite result: clinical hypotension occurred in 51% receiving ketamine versus 73% with etomidate (OR 0.39; 95% CI 0.22-0.67) 4. However, this single-center study had important confounders—more ketamine patients had septic shock and higher SOFA scores 4.

FDA Label Warnings

The FDA label explicitly states: "Decreases in blood pressure and heart rate, arrhythmias, and cardiac decompensation have also been observed" with ketamine, and it is contraindicated when blood pressure elevation would be hazardous 7.

Practical Recommendations

Risk Stratification

Monitor vital signs and cardiac function continuously during ketamine administration 7. The 2023 Critical Care Medicine guidelines suggest there is no difference between etomidate and ketamine regarding mortality or hypotension incidence overall, but acknowledge the mixed evidence 4.

Dosing Considerations

Interestingly, there was no difference in hypotension risk between ketamine doses ≤1.0 mg/kg versus >1.0 mg/kg, suggesting dose reduction may not mitigate this risk 2.

Alternative Considerations

The 2025 meta-analysis found that while ketamine increases peri-intubation hemodynamic instability, it probably decreases the need for continuous vasopressor infusions (RR 0.75; 95% CI 0.57-1.00) and results in less adrenal suppression compared to etomidate 3. This creates a complex risk-benefit calculation.

Bottom Line

Pending additional data, clinicians should not prioritize ketamine over etomidate based solely on concern for avoiding hemodynamic compromise 2. The traditional teaching that ketamine is hemodynamically protective does not hold in critically ill patients with depleted catecholamine stores 4. Selection of induction agent should account for individual patient factors, particularly sepsis severity and baseline hemodynamic status.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.